Carrygenes Bioengineering
UEI: GT8CF9MKJJ66
• CAGE: 71QG3
Overview
Awardee Type
Parent
Federal Capability Statement
Our company has the capability of bioengineering large, portable, self-replicating chromosomes and transferring the engineered chromosomes to a cell type of interest for functional output.
Keywords
Bioengineering, Cell and Gene Therapy
Headquarters
Savannah, GA
United States
United States
Most Recent Award
June 5, 2019
Calculating
Federal contract recipient
CARRYGENES BIOENGINEERING, LLC
dba CARRYGENES BIOENGINEERING LLC
(UEI GT8CF9MKJJ66, CAGE 71QG3)
is headquartered in Savannah GA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in December 2013 and
federally registered in
December 2013.
Federal Award Analysis
Carrygenes Bioengineering federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CARRYGENES BIOENGINEERING, LLC
DBA
CARRYGENES BIOENGINEERING LLC
UEI
GT8CF9MKJJ66
CAGE Code
71QG3
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 9, 2013
Initial Registration
Dec. 16, 2013
Last Registration
Aug. 2, 2024
Registration Activation
Aug. 2, 2024
Registration Expiration
July 31, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
GA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No